CN105695552A - Method using enzymatic method to prepare rare ginsenoside Rh1 - Google Patents

Method using enzymatic method to prepare rare ginsenoside Rh1 Download PDF

Info

Publication number
CN105695552A
CN105695552A CN201610219039.1A CN201610219039A CN105695552A CN 105695552 A CN105695552 A CN 105695552A CN 201610219039 A CN201610219039 A CN 201610219039A CN 105695552 A CN105695552 A CN 105695552A
Authority
CN
China
Prior art keywords
ginsenoside
glucosidase
beta
seqidno
rhamnosidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610219039.1A
Other languages
Chinese (zh)
Inventor
赵林果
赵东霞
解静聪
裴建军
李琦
房仙颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Forestry University
Original Assignee
Nanjing Forestry University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Forestry University filed Critical Nanjing Forestry University
Priority to CN201610219039.1A priority Critical patent/CN105695552A/en
Publication of CN105695552A publication Critical patent/CN105695552A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/20Preparation of steroids containing heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2445Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021Beta-glucosidase (3.2.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0104Alpha-L-rhamnosidase (3.2.1.40)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a method using an enzymatic method to prepare rare ginsenoside Rh1. The method is characterized in that beta-glucosidase from Thermotoga petrophila and alpha-rhamnosidase from Aspergillus niger are utilized to degrade ginsenoside Re so as to produce the Rh1. The method has the advantages that the enzymatic method is used to catalyze the ginsenoside Re to produce the rare ginsenoside Rh1, the produced rare ginsenoside Rh1 is high in purity, no byproducts are produced, the enzymatic method is high in conversion efficiency, and mole yield reaches 95%.

Description

A kind of enzyme process prepares the method for rare ginsenoside Rh1
Technical field
The invention belongs to biomedicine field, the preparation method relating to rare ginsenoside Rh1, particularly relate to utilize and recombinant expressed derive from α-rhamnosidase and beta-glucosidase converts ginsenoside Re and generates Rh1。
Background technology
Radix Ginseng (Panaxginseng) is the rare Chinese medicine that Asia is traditional, and ginsenoside is the bioactive substance that it is main, has the features such as biological activity is notable, pharmacological action is unique。Raising along with analytical technology level, the chemical composition of ginsenoside obtains further clearly, now isolation identification goes out more than 180 kind ginsenoside monomers, wherein 5 kinds of main saponin (ginsenoside Rb1, Rb2, Rc, Re and Rg1) account for more than the 80% of total saponins, and ginsenoside (Rg3, Rh2, CompoundK, Rg2, F1 and Rh1) content is very low, it is called rare saponin (AppliedMicrobiologyandBiotechnology, 2012,94:673-682), but its pharmacologically active is better than the ginsenoside of above-mentioned high-load。
Rare saponin Rh1 has startup and strengthens immunne response, promotes the physiological actions such as hepatocyte growth, killing tumor cell, and aging resistance, can be used for regulating body's immunity, treats and prevents hepatitis etc.。But rare saponin Rh1 content in plant is very low, extracting directly complex process, and cost is too high。And ginsenoside Re's content in Radix Ginseng total saponins is higher, to rare ginsenoside Rh1, there is similar chemical constitution, therefore, it can obtain Rh1 (Fig. 1) by ginsenoside Re carries out conversion, but need the rhamanopyranosyl on specific degraded C20 position and the glucosyl group on C6 position。
Utilize chemical method and biotransformation method ginsenoside Re can be converted into Rh1。But chemical transformation is not used because of shortcomings such as its reaction are violent, poor selectivity, by-product are many。The features such as bioconversion has reaction condition gentleness, and specificity is good and favored。The biotransformation method of current ginsenoside mainly has microbe transformation method and enzyme transforming process。Microbe transformation method is complicated because of its transformation system, it is easy to produce by-product, the purity of product is had certain impact。As, Dong Aling etc. finds that aspergillus niger and Absidia coerulea can convert ginsenoside Rg1 and produce ginsenoside Rh1, but it is longer to there is the transformation period, and has the shortcomings such as other saponin by-product (China's medicine, 2001,10 (3): 115-118)。Enzymatic conversion method is avoided that the defect of microbe transformation method, but various enzymes are different to the specificity of substrate, the glycosidic bond type of degraded is also different, therefore, finds and can become research key by glycoside hydrolase efficient, that selective degradation ginsenoside Re produces ginsenoside Rh1。At present, but without the report utilizing enzymatic conversion ginsenoside Re to produce ginsenoside Rh1。
Summary of the invention
Solving the technical problem that: the invention provides a kind of method that enzyme process prepares rare ginsenoside Rh1, the recombinase that the method uses is respectively derived from the beta-glucosidase of Thermotogapetrophila and the α-rhamnosidase of aspergillus niger (Aspergillusniger)。
Technical scheme: a kind of enzyme process prepares the method for rare ginsenoside Rh1, utilizing and derive from the beta-glucosidase of Thermotogapetrophila and the α-rhamnosidase of aspergillus niger (Aspergillusniger), degraded ginsenoside Re produces Rh1。
The nucleotide sequence of described beta-glucosidase is such as shown in SEQIDNO:1, and aminoacid sequence is such as shown in SEQIDNO:2。
The nucleotide sequence of described α-rhamnosidase is such as shown in SEQIDNO:3, and aminoacid sequence is such as shown in SEQIDNO:4。
Described beta-glucosidase is by recombinant expressed preparation, and step is:
(1) with the Thermotogapetrophila genomic DNA of extraction for template, being classified as forward primer with having the nucleotides sequence shown in SEQIDNO:5 and have the nucleotides sequence shown in SEQIDNO:6 and be classified as downstream primer, pcr amplification obtains the DNA molecular of beta-glucosidase;
(2) DNA molecular of above-mentioned beta-glucosidase and pET-20b are carried out double digestion with NdeI and XhoI respectively, connect and convert the recombiant plasmid obtaining the DNA molecular containing beta-glucosidase;
(3) by recombinant plasmid transformed expressive host E.coliBL21 (DE3) of above-mentioned acquisition, IPTG induces beta-glucosidase expression of enzymes, collects thalline, smudge cells, 80 DEG C of heat treatments 40 minutes, it is thus achieved that the beta-glucosidase of purification。
Described α-rhamnosidase is by recombinant expressed preparation, and step is:
(1) with aspergillus niger (Aspergillusniger) NL-1cDNA of extraction for template, being classified as forward primer with having the nucleotides sequence shown in SEQIDNO:7 and have the nucleotides sequence shown in SEQIDNO:8 and be classified as downstream primer, pcr amplification obtains the DNA molecular of α-rhamnosidase;
(2) DNA molecular of above-mentioned beta-glucosidase and pET-20b are carried out double digestion with NdeI and XhoI respectively, connect and convert the recombiant plasmid obtaining the DNA molecular containing α-rhamnosidase;
(3) by recombinant plasmid transformed expressive host E.coliBL21 (DE3) of above-mentioned acquisition, induce α-rhamnoside expression of enzymes, collect thalline, smudge cells, be centrifuged and obtain α-rhamnosidase。
Described enzyme process prepares the degradation condition in the method for rare ginsenoside Rh1:
(1) 1g/L ginsenoside Re, under beta-glucosidase 0.2U, pH5.0,85 DEG C condition, degrade 1h;
(2) above-mentioned reactant liquor being added α-rhamnosidase 6.6U, adjusting pH is under 6.5,35 DEG C of conditions, and degrade 1h, and ginsenoside Re may finally be converted into ginsenoside Rh1, and molar yield is 95%。
Beneficial effect: 1. produce rare ginsenoside Rh1 by enzyme law catalysis ginsenoside Re, the rare ginsenoside Rh1 purity of generation is high, it does not have by-product。2. the efficiency of enzymatic conversion method is high, and molar yield reaches 95%。
Accompanying drawing explanation
Fig. 1 is the structural representation of ginsenoside Re and Rh1;
Fig. 2 is that activity of beta-glucosidase is affected figure by the temperature that the embodiment of the present invention provides;
Fig. 3 is that activity of beta-glucosidase is affected figure by the pH that the embodiment of the present invention provides;
Fig. 4 is the Re that the embodiment of the present invention the provides time plot being converted into Rg2;
Fig. 5 is that α-rhamnosidase activity is affected figure by the temperature that the embodiment of the present invention provides;
Fig. 6 is that α-rhamnosidase activity is affected figure by the pH that the embodiment of the present invention provides;
Fig. 7 is the Rg2 that the embodiment of the present invention the provides time plot being converted into Rh1。
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment is only a part of embodiment of the present invention rather than whole embodiments。Based on the embodiment in the present invention, the every other embodiment that those of ordinary skill in the art obtain under not making creative work premise, broadly fall into the scope of protection of the invention。
In order to be further appreciated by the present invention, below in conjunction with embodiment, the present invention will be described in detail, and wherein, if no special instructions, the various reaction reagents related in embodiment all can be commercially available by commercial channel;If no special instructions, the concrete operations related in embodiment are referring to " the Molecular Cloning: A Laboratory guide third edition "。
Embodiment 1: the structure of recombiant plasmid pET-20b-bgl
The cultivation of 1.1Thermotogapetrophila
Thermotogapetrophila is purchased from DSMZ DSMZ (www.dsmz.de) and is numbered DSM13995。Its culture medium prescription is: 10g/L soluble starch, 3g/L yeast powder, 5g/L tryptone, 5g/L meat extract, 10g/L2-morpholino b acid, 10mg/L seven ferric sulfate hydrate, 1mg/L "diazoresorcinol", adjusting pH is 7.2, boils inflated with nitrogen, after removing oxygen, culture medium loads anaerobism bottle sterilizing under anaerobic。Inoculate according to 0.5wt.% inoculum concentration with syringe, 85 DEG C of static gas wave refrigerator 24h, collect cell。
The extraction of 1.2 genomic DNAs
(1) quiescent culture Thermotogapetrophila24h, takes the centrifugal 10min of 30mL bacterium solution 4,000g and collects cell。
(2) with the resuspended thalline of 9.5mLTE buffer, 0.5mL10wt.% sodium lauryl sulphate (SDS) and 50 μ L E.C. 3.4.21.64 (20mg/mL), mix homogeneously, 37 DEG C of insulation 1h are added。
(3) 1.8mL5mol/LNaCl, 1.5mL cetyltriethylammonium bromide (CTAB)/NaCl is added, mixing, 65 DEG C of incubation 20min。
(4) equal-volume chloroform/isoamyl alcohol (volume ratio 24:1) is added, mixing, 6,000g centrifugal 10min。
(5) for preventing shearing force from causing genomic DNA to rupture, with thick mouth suction pipe, supernatant is proceeded in another centrifuge tube, add equal-volume phenol/chloroform/isoamyl alcohol mixing (volume ratio 25:24:1), 6,000g centrifugal 10min。
(6) in another centrifuge tube, add 0.6 times of volume isopropanol, rock to white thread DNA precipitation high-visible gently。
(7) with suction pipe, DNA is wound on it, clean in 70vt.% ethanol。
(8) with sterile toothpick, DNA is scraped from suction pipe, proceed in 1.5mL centrifuge tube。
(9) air-dry under room temperature, add 500 μ LTE buffer solution。
(10) 50 μ L nucleic acid-protein detector detection DNA concentration are taken。
The structure of 1.3 recombiant plasmid pET-20b-bgl
Primer is designed: (SEQIDNO:5) underscore represents NdeI restriction enzyme site according to the extremely heat-resisting beta-glucosidase gene (YP_001244492.1) of known Thermotogapetrophila;(SEQIDNO:6) underscore represents XhoI restriction enzyme site, and removes termination codon;With the genomic DNA of the Thermotogapetrophila of extraction for template, carrying out pcr amplification with the primer of synthesis, the condition of amplification is 94 DEG C, 3min;30 circulations (94 DEG C, 30s;58 DEG C, 30s;72 DEG C, 2min10s);72 DEG C, 10min;Reaction stops, 4 DEG C of insulations。Reclaim test kit by gel pcr amplification product is purified。Obtain the extremely heat-resisting beta-glucosidase gene of T.petrophila。
Obtain the extremely heat-resisting beta-glucosidase gene of Thermotogapetrophila and pET-20b carries out double digestion with NdeI and XhoI respectively, and recovery of tapping rubber respectively, concentrate latter 16 DEG C to connect overnight, product will be connected and convert escherichia coli Top10F ' competent cell, converted product is applied to 37 DEG C of incubated overnight on LB (add ampicillin to final concentration 100mg/L) solid medium, inoculate after several single bacterium colony cultivates 8-10 hour in LB (add ampicillin to final concentration 100mg/L) fluid medium, collect thalline and extract plasmid, digestion verification removes empty plasmid, recombiant plasmid is carried out determining nucleic acid sequence, obtain correct recombinant expression carrier pET20b-bgl。
2. recombinate the expression of extremely heat-resisting beta-glucosidase and purification
Recombiant plasmid pET-20b-bgl is converted e. coli bl21 (DE3) Host Strains (Novagen), in LB flat board (the LB culture medium: tryptone 10g/L containing Amp (100 μ g/mL), yeast extract 5g/L, NaCl5g/L, agar 15g/L) on through 37 DEG C of overnight incubation, choosing transformant (100 μ g/mLAmp) 37 DEG C in the LB culture medium of 200mL, 200rpm shaken cultivation is to OD600When being 0.6, add final concentration of 0.5mM isopropyl ss-D-Thiogalactopyranoside (IPTG) derivant, 30 DEG C of inducing culture 8h, with High speed refrigerated centrifuge by culture fluid at 4 DEG C, with 13,000rpm centrifugal 15min, collect thalline, supernatant is gone to add sterilized water, ultrasonic disruption cell, subsequently 70 DEG C of heat treatment 30min, with High speed refrigerated centrifuge by culture fluid at 4 DEG C, with 13,000rpm centrifugal 15min, supernatant is the pure enzyme of extremely heat-resisting beta-glucosidase of recombinating。
3. the extremely heat-resisting beta-glucosidase enzymatic conversion Re that recombinates is the condition of Rg2
3.1 enzyme activity determinations
Reaction system 200 μ L, 10 μ L20mmol/LPNPG add 100 μ L100mmol/L citrate-phosphate disodium hydrogen buffer (pH5.0) and appropriate water, first hatch 2min at 90 DEG C, add 5 μ L enzyme liquid (being diluted to suitable multiple) and react 10min。Reaction is added immediately the Na of 600 μ L1M after terminating2CO3, under 405nm, measure its light absorption value with spectrophotometer。Enzyme activity unit (U) is defined as: under condition determination, and the enzyme amount used by 1 μm of ol ginsenoside Rg2 of generation per minute is 1 enzyme activity unit。
The mensuration of 3.2 optimal reactive temperatures
Within the scope of 70-90 DEG C, every 5 DEG C, measure enzyme respectively and live。Buffering is 100mmol/L citrate-phosphate disodium hydrogen buffer, and pH5.0, it has been found that the optimal reactive temperature of extremely heat-resisting glycosidase is 85 DEG C (Fig. 2), higher reaction temperature can make substrate saponin Re dissolubility in water increase。
The mensuration of 3.3 optimal reaction pH
Under different pH (4.0-8.0,100mmol/L citrate-phosphate disodium hydrogen buffer) conditions, 85 DEG C measure enzyme respectively and live, it has been found that the optimal reaction pH of extremely heat-resisting glycosidase is 5.0 (Fig. 3)。
4. ginsenoside Re converts production ginsenoside Rg2
The concentration of ginsenoside Re is 1g/L, and conversion condition is 85 DEG C, pH5.0100mmol/L citrate-phosphate disodium hydrogen buffer, and different time points (0,5,10,20,30,40,50,60min) is separately sampled, is detected by HPLC。Found that ginsenoside Re can be converted into ginsenoside Rg2 by extremely heat-resisting glycosidase (0.2U) in 60min, molar yield is 100% (Fig. 4)。
5. the structure of recombiant plasmid pET-20b-Rha
The cultivation of 5.1 aspergillus nigers (Aspergillusniger) NL-1
AspergillusnigerNL-1 (" aspergillus niger is secreted the impact of beta-glucosidase by carbon source and nitrogenous source ", " Nanjing Forestry University's journal: natural science edition ", 2008,32 (6): 1-4), its culture medium prescription is: rhamnose 10g/L, MgSO4·7H2O0.5g/L, KH2PO41.5g/L, (NH4)2SO44g/L, ZnSO4·7H2O0.09g/L, CaCl20.1g/L, yeast extract 1g/L, bean cake 2.0g/L, peptone 2.0g/L。At 30 DEG C, 180rpm cultivates 3-4 days。
The synthesis of 5.2cDNA
The mycelium phosphate buffer solution getting the aspergillus niger of collection cleans after once, it is used in pulverized under liquid nitrogen mycelium to Powdered, collect in 2mL centrifuge tube, acutely shake after adding 1mLTrizol, at 4 DEG C, after the centrifugal 10min of 12000g, transfer supernatant to 2mL centrifuge tube adds at 200 μ L chloroforms concussion 15s mix latter 30 DEG C and hatches 2-3min, at 4 DEG C, the centrifugal 10min of 12000g takes supernatant, add the centrifugal 10min of 12000g at 0.8 times of volume isopropanol mixes latter 4 DEG C, remove after supernatant that (DEPC processed with 75wt.% ethanol water, eliminate mRNA enzyme) clean 2 times after at 4 DEG C the centrifugal 5min of 7500g be precipitated, after making its natural drying, add appropriate DEPC water dissolution RNA precipitate, as template ribonucleic acid, preserve at-20 DEG C。
With aspergillus niger AspergillusnigerNL-1 bacterial strain RNA for template, utilize " PrimeScriptTM1stStrandcDNASynthesisKit " test kit (being purchased from Takara company) reverse transcription synthesis cDNA Article 1 chain (concrete reactant liquor proportioning reference reagent box)。
The structure of 5.3 recombiant plasmid pET-20b-Rha
Primer is designed: (SEQIDNO:7) underscore represents NdeI restriction enzyme site according to known AspergillusnigerNL-1 α-rhamnose glycosidase genes (accession number: XM_001402229.1);(SEQIDNO:8) underscore represents Hind III site, and removes termination codon;With the genome cDNA of the AspergillusnigerNL-1 of extraction for template, carrying out pcr amplification with the primer of synthesis, the condition of amplification is 94 DEG C, 3min;30 circulations (94 DEG C, 30s;52 DEG C, 30s;72 DEG C, 2min50 ');72 DEG C, 10min;Reaction stops, 4 DEG C of insulations。Reclaim test kit by gel pcr amplification product is purified。Obtain A.nigerNL-1 α-rhamnose glycosidase genes。
AspergillusnigerNL-1 α-rhamnose the glycosidase genes obtained and pET-20b carry out double digestion with NdeI and Hind III respectively, and recovery of tapping rubber respectively, concentrate latter 16 DEG C to connect overnight, product will be connected and convert escherichia coli Top10F ' competent cell, converted product is applied to 37 DEG C of incubated overnight on LB (add ampicillin to final concentration 100mg/L) solid medium, inoculate after several single bacterium colony cultivates 8-10 hour in LB (add ampicillin to final concentration 100mg/L) fluid medium, collect thalline and extract plasmid, digestion verification removes empty plasmid, recombiant plasmid is carried out determining nucleic acid sequence, obtain correct recombinant expression carrier pET20b-Rha。
6. the expression of recombinant alpha-rhamnosidase and purification
Recombiant plasmid pET-20b-Rha is converted e. coli bl21 (DE3) Host Strains (Novagen), in LB flat board (the LB culture medium: tryptone 10g/L containing Amp (100 μ g/mL), yeast extract 5g/L, NaCl5g/L, agar 15g/L) on through 37 DEG C of overnight incubation, choose transformant (100 μ g/mLAmp) 37 DEG C of inducing culture 12h in the LB culture medium of 200mL, with High speed refrigerated centrifuge by culture fluid at 4 DEG C, with 13, 000rpm is centrifuged 15min, collect thalline, supernatant is gone to add sterilized water, ultrasonic disruption cell, with High speed refrigerated centrifuge by culture fluid at 4 DEG C, with 13, 000rpm is centrifuged 15min, take supernatant, it is purified with Ni-NTA affinity column。The recombinase obtained is the pure enzyme of recombinant alpha-rhamnosidase。
The specific operation process of purification:
A. the process of sample
(1) by washed thalline, resuspended with 1 × BindingBuffer8mL, supersonic wave wall breaking。
(2) after breaking cellular wall, 13,000g centrifugal 30min, take supernatant and be sample。
B. pillar is processed
(1) 1mL filler dress post is taken。
(2) with the aseptic washing pillar of 3mL。
(3) pillar is washed with the 1 × ChargeBuffer of 5mL。
(4) pillar is washed with the 1 × BindingBuffer of 3mL。
C. loading
(1) sample is added pillar, 6 about per minute of coutroi velocity。
(2) wash pillar with 3mL1 × BindingBuffer, remove unconjugated protein。
(3) wash pillar with the 4mL eluent containing 20mM imidazoles, remove foreign protein。
(4) wash pillar with the eluent of 100mmol/L imidazoles, destination protein is eluted。
(5) pillar is washed with 4mL1 × StripBuffer。
Recombinant alpha-the rhamnosidase of purification is obtained by this process。
7. recombinant alpha-rhamnoside enzymatic conversion Rg2 is the condition of Rh1
7.1 enzyme activity determinations
Reaction system 200 μ L, adds 100 μ L100mmol/L citrate-phosphate disodium hydrogen buffer (pH6.5) and 85 μ L water in 40 μ L5mmol/LpNPR, first hatch 2min at 35 DEG C, add 10 μ L enzyme liquid and (make OD405Value between 0.2~1.0) reaction 10min。Reaction is added immediately the Na of 600 μ L1M after terminating2CO3, under 405nm, measure its light absorption value with spectrophotometer。Enzyme activity unit (U) is defined as: under condition determination, and the enzyme amount used by 1 μm of olPNP of generation per minute is 1 enzyme activity unit。
The mensuration of 7.2 optimal reactive temperatures
Within the scope of 25-45 DEG C, every 5 DEG C, measure enzyme respectively and live。Buffering is 100mmol/L citrate-phosphate disodium hydrogen buffer, pH6.5, it has been found that the optimal reactive temperature of α-rhamnosidase is 35 DEG C (Fig. 5)。
The mensuration of 7.3 optimal reaction pH
Under different pH (5.0-7.5,100mmol/L citrate-phosphate disodium hydrogen buffer) conditions, 35 DEG C measure enzyme respectively and live, it has been found that the optimal reaction pH of α-rhamnosidase is 6.5 (Fig. 6)。
8. ginsenoside Rg2 converts and produces ginsenoside Rh1
Ginsenoside Rg2 is the reactant liquor in above-mentioned 4.th part, and conversion condition is 35 DEG C, pH6.550mmol/L citrate-phosphate disodium hydrogen buffer, different time points (0,5,10,20,30,40,50,60min) separately sampled, detected by HPLC。Found that ginsenoside Rg2 can be converted into ginsenoside Rh1 by α-rhamnosidase (6.6U) in 60min, molar yield is 95% (Fig. 7)。
SEQUENCELISTING
<110>Nanjing Forestry University
<120>a kind of method that enzyme process prepares rare ginsenoside Rh1
<130>
<160>8
<170>PatentInversion3.3
<210>1
<211>2166
<212>DNA
<213>Thermotogapetrophila
<400>1
atgatgggaaagatcgatgaaatcctttcacagctgactattgaagaaaaagtgaaactt60
gtagtgggggttggtcttccaggactttttggaaatccacattccagagtggcaggtgca120
gctggagaaacgcatcctgttccgaggcttggaattccttctttcgttctggccgacggt180
cccgcgggcctcagaataaatcccacaagagagaacgacgaaaacacctattacacaaca240
gcgtttcctgttgaaatcatgctcgcttccacctggaacaaagatcttctggaagaagta300
ggaaaagctatgggagaagaagtcagggaatacggtgtcgatgtgcttcttgcacctgcg360
atgaacattcacaggaaccctctttgtggaaggaatttcgagtattattcagaagatcct420
gtcctttccggtgaaatggcttcagcctttgtcaagggagttcaatctcaaggggtggga480
gcctgcataaaacactttgtcgcgaacaaccaggaaacgaacaggatggtagtggacacg540
atcgtgtccgagcgagccctcagagaaatatatctgaaaggttttgaaattgccgtcaag600
aaagcaagaccctggaccgtgatgagcgcttacaacaaactgaatggaaaatactgttca660
cagaacgaatggcttttgaagaaggttctcagggaagaatggggatttgacggtttcgtg720
atgagcgactggtacgcgggagacaaccctgtagaacagctcaaggccggaaacgatatg780
atcatgcctggaaaagcgtatcaggtgaacacggaaagaagagatgaaatagaagaaatc840
atggaggcgttgaaggagggaagactcagtgaggaagtcctgaacgaatgtgtgagaaac900
atcctcaaagttcttgtgaacgcgccttcctttaaagggtacaggtactcgaacaaaccg960
gacctcgaatctcacgcgaaagttgcctacgaagcaggtgtggagggtgttgtccttctt1020
gagaacaacggtgttcttccattcgatgaaagtatccatgtcgccgtctttggcaccggt1080
caaatcgaaacaataaagggaggaacgggaagtggagacacccatccgagatacacgatc1140
tctatccttgaaggcataaaagaaagaaacatgaagttcgacgaagaactcacctccatc1200
tatgaggattacatcaaaaagatgagagaaacagaggaatataaacccagaactgactcc1260
tggggaacggttataaaaccgaaacttccagagaactttctctcagaaaaagagataaag1320
aaggctgcgaagaaaaacgatgctgcagttgttgtaatcagtaggatctccggtgaggga1380
tacgacagaaagccggtgaaaggtgacttctacctctccgatgacgagctggagctcata1440
aaaacagtctcaagggaattccacgaacagggtaagaaggttgtggttcttctcaacatc1500
ggaagtcccattgaagttgcaagctggagagatcttgtggatggaatccttctcgtctgg1560
caagcaggacaggagatgggaagaatagtggccgatgttcttgtgggaagggtaaacccc1620
tccggaaaacttccaacgaccttcccgaaggattactcggacgttccatcctggacgttc1680
ccaggagagccaaaggacaatccgcaaagagtggtgtacgaggaagacatctacgtggga1740
tacaggtactacgacacctttggtgtggaacctgcctacgagttcggctacggcctctct1800
tacacaaagtttgaatacaaagatttaaagatcgctatcgacggagatatactcagagtg1860
tcgtacacgatcacaaacaccggggacagagctggaaaggaagtctcacaggtttatgtc1920
aaagctccaaaagggaaaatagacaaacccttccaggagctgaaagcgttccacaaaaca1980
aaacttttgaacccgggtgaatccgaaaagatctttctggaaattcctcttagagatctt2040
gcgagtttcgatgggaaagaatgggttgtcgagtcaggagaatacgaggtcagggtcggt2100
gcatcttcgagggatataaggttgagagatatttttctggttgagggagagaagagattc2160
aaacca2166
<210>2
<211>722
<212>PRT
<213>Thermotogapetrophila
<400>2
MetMetGlyLysIleAspGluIleLeuSerGlnLeuThrIleGluGlu
151015
LysValLysLeuValValGlyValGlyLeuProGlyLeuPheGlyAsn
202530
ProHisSerArgValAlaGlyAlaAlaGlyGluThrHisProValPro
354045
ArgLeuGlyIleProSerPheValLeuAlaAspGlyProAlaGlyLeu
505560
ArgIleAsnProThrArgGluAsnAspGluAsnThrTyrTyrThrThr
65707580
AlaPheProValGluIleMetLeuAlaSerThrTrpAsnLysAspLeu
859095
LeuGluGluValGlyLysAlaMetGlyGluGluValArgGluTyrGly
100105110
ValAspValLeuLeuAlaProAlaMetAsnIleHisArgAsnProLeu
115120125
CysGlyArgAsnPheGluTyrTyrSerGluAspProValLeuSerGly
130135140
GluMetAlaSerAlaPheValLysGlyValGlnSerGlnGlyValGly
145150155160
AlaCysIleLysHisPheValAlaAsnAsnGlnGluThrAsnArgMet
165170175
ValValAspThrIleValSerGluArgAlaLeuArgGluIleTyrLeu
180185190
LysGlyPheGluIleAlaValLysLysAlaArgProTrpThrValMet
195200205
SerAlaTyrAsnLysLeuAsnGlyLysTyrCysSerGlnAsnGluTrp
210215220
LeuLeuLysLysValLeuArgGluGluTrpGlyPheAspGlyPheVal
225230235240
MetSerAspTrpTyrAlaGlyAspAsnProValGluGlnLeuLysAla
245250255
GlyAsnAspMetIleMetProGlyLysAlaTyrGlnValAsnThrGlu
260265270
ArgArgAspGluIleGluGluIleMetGluAlaLeuLysGluGlyArg
275280285
LeuSerGluGluValLeuAsnGluCysValArgAsnIleLeuLysVal
290295300
LeuValAsnAlaProSerPheLysGlyTyrArgTyrSerAsnLysPro
305310315320
AspLeuGluSerHisAlaLysValAlaTyrGluAlaGlyValGluGly
325330335
ValValLeuLeuGluAsnAsnGlyValLeuProPheAspGluSerIle
340345350
HisValAlaValPheGlyThrGlyGlnIleGluThrIleLysGlyGly
355360365
ThrGlySerGlyAspThrHisProArgTyrThrIleSerIleLeuGlu
370375380
GlyIleLysGluArgAsnMetLysPheAspGluGluLeuThrSerIle
385390395400
TyrGluAspTyrIleLysLysMetArgGluThrGluGluTyrLysPro
405410415
ArgThrAspSerTrpGlyThrValIleLysProLysLeuProGluAsn
420425430
PheLeuSerGluLysGluIleLysLysAlaAlaLysLysAsnAspAla
435440445
AlaValValValIleSerArgIleSerGlyGluGlyTyrAspArgLys
450455460
ProValLysGlyAspPheTyrLeuSerAspAspGluLeuGluLeuIle
465470475480
LysThrValSerArgGluPheHisGluGlnGlyLysLysValValVal
485490495
LeuLeuAsnIleGlySerProIleGluValAlaSerTrpArgAspLeu
500505510
ValAspGlyIleLeuLeuValTrpGlnAlaGlyGlnGluMetGlyArg
515520525
IleValAlaAspValLeuValGlyArgValAsnProSerGlyLysLeu
530535540
ProThrThrPheProLysAspTyrSerAspValProSerTrpThrPhe
545550555560
ProGlyGluProLysAspAsnProGlnArgValValTyrGluGluAsp
565570575
IleTyrValGlyTyrArgTyrTyrAspThrPheGlyValGluProAla
580585590
TyrGluPheGlyTyrGlyLeuSerTyrThrLysPheGluTyrLysAsp
595600605
LeuLysIleAlaIleAspGlyAspIleLeuArgValSerTyrThrIle
610615620
ThrAsnThrGlyAspArgAlaGlyLysGluValSerGlnValTyrVal
625630635640
LysAlaProLysGlyLysIleAspLysProPheGlnGluLeuLysAla
645650655
PheHisLysThrLysLeuLeuAsnProGlyGluSerGluLysIlePhe
660665670
LeuGluIleProLeuArgAspLeuAlaSerPheAspGlyLysGluTrp
675680685
ValValGluSerGlyGluTyrGluValArgValGlyAlaSerSerArg
690695700
AspIleArgLeuArgAspIlePheLeuValGluGlyGluLysArgPhe
705710715720
LysPro
<210>3
<211>2766
<212>DNA
<213>Aspergillusniger
<400>3
atggccagccaaatcttcattgaaacccctacagttgagcaacactcaaccgggtttggc60
attggaactgcgactccgcgtctgtcatggcgattcctcaccaccgacagtagtcctcgc120
gactgggagcagacggcctacgaagtggaagttgttcgttccggatctcgagaggaaacc180
taccatgtgaacagcagtgcatcggtgctggtcccttggcccagtggcccactacaatcc240
cgggaaatcgcacaggtccgtgttcgagcatacgggtgcagcgctggcaaggagcagcag300
agtgactgtgccaccgcttggtctccctggcggactattgagtgtggactactcgaccgc360
gctgactgggtagcccgacctattgccagtcctgaggaaccacagccggatcatccatta420
cgaccggtgcgattccgtaaagagttccaactccctgcggcaggtaccatagaaaaagct480
cgcctttatatcacgagctttggagtataccgcgccttcatcaacgggcatcgagtaggg540
gatcagtgtctcgcgcccggatggaccagctaccgccatcgcttgaactatcaagtgttc600
gacatcgcgtccctcctgaatgctgaaggtcctaatgtccttgcggtagaggttgcagag660
ggctggtacgccactcgcctcggcttccttggcgggcgaagacagctgtatggggatcga720
ctggccgtgttggcccagctggagatccaacttggatctaatggagaccgattctatatg780
tctaccgatagcacctggacgtgtactcccagtgccatcatccggagtgagctctatgac840
ggcgaggtttacgatacccgtgaagaagattcgacctggaactgcttgcgtcttgaccaa900
acctcccgctgggtggccgttcaggaactcgagttcccaaccgcagccttggtggcaccg960
aacgctcccccagtccgtatcaccgaggagatatctccagtctccgtccagaagacccca1020
tccggtgccaccgtcatcgacttcggccagaacctggtcggtcgactttgcgtgcgctcg1080
ttgaacaagccctcgggctctcgcgtttccttcattcacgccgaagtgcttgagaatggc1140
gagctcggggttcgacccctgcgacacgccaagtgcaccgacgaagtcattctaagtgat1200
acagagctggtagattggtcgcctcagtatacattccacgggtttcggttcgtccaggtc1260
aatggttgggatgaagaaagcgatggatcactgctcctcaacatcaacgcgcttgtgatg1320
cacactgatatgactcgcagcggatggttttcctgctcgcaccctatggtcaatcaactc1380
cacaccaatgcctggtggagtatgcgtgggaatttcctttccatccctaccgattgcccc1440
cagagggatgaacgcctcggctggaccggggatattcagatattctgcccatcggccaac1500
ttcctctacaatactgctggcatgctgagtgactggttgcaagatgtcgcggccgagcag1560
ctgagggagaaagatggttgcgtgcctccatttacagtccccaatatcattagtgagacc1620
ctgtggccgcatacgccgcaggctgtatgggatgatgtggtgatcctaacgccctgggcc1680
ctctaccggtcgtatggggacagtgaaattctccgccgtcaatatgaaagcatgctcgcc1740
tggatcgatcgcggcatccgtcgcggctcagatggactctgggaccctgagctttggcaa1800
ctgggagactggttagacccaacagcgccgcccgaggaacctggggatgcacgcaccagc1860
ggaaccctcgttgctgatgcctatctcgtgcacatcacttcggtgatgtccgaaatcagc1920
caggtcctcggccagagccaggatgccgcacggtttaagacggactataatcgactcaag1980
gcgaggttccaggccaagtatataacggcgactgggttactagtcggcgatacccaaacg2040
gcgcttagccttgccatcgtgtacgaccttcactccacccctgaagcagcgcaagcagca2100
gcatcacgtctcgtccacctcgtccggctcgccaagtttcgcgtcgccaccgggttcgcg2160
ggcactccaatcatcacgcatgctctcaccaagagcggaaatccccagatcgcctaccgg2220
atgttgctagagaaatctcgtccgtcgtggatgtatcccatcaccatgggggcgacgacc2280
atgtgggagaggtgggacagcatgctccccgacgggtccatcaaccctggcgaaatgacc2340
agcttcaaccactacgccctgggttcgatcatcaactggctgcactccgttgtagccggc2400
gtcagccctctggccccaggctggaaacacatacaggtcgccccgacacctgggcctaca2460
attcactctgctgaagccatgtatgacactccttatgggcgactggaatgccggtggtcg2520
atcgagactgatgcagaccgcttccacatggacctgttgataccccctaactctcgcgcg2580
cgtgtaatcttgccaactcgagagaagctatcacagcccgttggttctcgtgaagacgga2640
ggcttttgggtgggttcggggcgtcacaagttctcagcgaccttcgagtggaaggactat2700
tctagggactggccaccaaagcctctgaatccgattatgcgtgaacctgaaccggaggat2760
attgcc2766
<210>4
<211>922
<212>PRT
<213>Aspergillusniger
<400>4
MetAlaSerGlnIlePheIleGluThrProThrValGluGlnHisSer
151015
ThrGlyPheGlyIleGlyThrAlaThrProArgLeuSerTrpArgPhe
202530
LeuThrThrAspSerSerProArgAspTrpGluGlnThrAlaTyrGlu
354045
ValGluValValArgSerGlySerArgGluGluThrTyrHisValAsn
505560
SerSerAlaSerValLeuValProTrpProSerGlyProLeuGlnSer
65707580
ArgGluIleAlaGlnValArgValArgAlaTyrGlyCysSerAlaGly
859095
LysGluGlnGlnSerAspCysAlaThrAlaTrpSerProTrpArgThr
100105110
IleGluCysGlyLeuLeuAspArgAlaAspTrpValAlaArgProIle
115120125
AlaSerProGluGluProGlnProAspHisProLeuArgProValArg
130135140
PheArgLysGluPheGlnLeuProAlaAlaGlyThrIleGluLysAla
145150155160
ArgLeuTyrIleThrSerPheGlyValTyrArgAlaPheIleAsnGly
165170175
HisArgValGlyAspGlnCysLeuAlaProGlyTrpThrSerTyrArg
180185190
HisArgLeuAsnTyrGlnValPheAspIleAlaSerLeuLeuAsnAla
195200205
GluGlyProAsnValLeuAlaValGluValAlaGluGlyTrpTyrAla
210215220
ThrArgLeuGlyPheLeuGlyGlyArgArgGlnLeuTyrGlyAspArg
225230235240
LeuAlaValLeuAlaGlnLeuGluIleGlnLeuGlySerAsnGlyAsp
245250255
ArgPheTyrMetSerThrAspSerThrTrpThrCysThrProSerAla
260265270
IleIleArgSerGluLeuTyrAspGlyGluValTyrAspThrArgGlu
275280285
GluAspSerThrTrpAsnCysLeuArgLeuAspGlnThrSerArgTrp
290295300
ValAlaValGlnGluLeuGluPheProThrAlaAlaLeuValAlaPro
305310315320
AsnAlaProProValArgIleThrGluGluIleSerProValSerVal
325330335
GlnLysThrProSerGlyAlaThrValIleAspPheGlyGlnAsnLeu
340345350
ValGlyArgLeuCysValArgSerLeuAsnLysProSerGlySerArg
355360365
ValSerPheIleHisAlaGluValLeuGluAsnGlyGluLeuGlyVal
370375380
ArgProLeuArgHisAlaLysCysThrAspGluValIleLeuSerAsp
385390395400
ThrGluLeuValAspTrpSerProGlnTyrThrPheHisGlyPheArg
405410415
PheValGlnValAsnGlyTrpAspGluGluSerAspGlySerLeuLeu
420425430
LeuAsnIleAsnAlaLeuValMetHisThrAspMetThrArgSerGly
435440445
TrpPheSerCysSerHisProMetValAsnGlnLeuHisThrAsnAla
450455460
TrpTrpSerMetArgGlyAsnPheLeuSerIleProThrAspCysPro
465470475480
GlnArgAspGluArgLeuGlyTrpThrGlyAspIleGlnIlePheCys
485490495
ProSerAlaAsnPheLeuTyrAsnThrAlaGlyMetLeuSerAspTrp
500505510
LeuGlnAspValAlaAlaGluGlnLeuArgGluLysAspGlyCysVal
515520525
ProProPheThrValProAsnIleIleSerGluThrLeuTrpProHis
530535540
ThrProGlnAlaValTrpAspAspValValIleLeuThrProTrpAla
545550555560
LeuTyrArgSerTyrGlyAspSerGluIleLeuArgArgGlnTyrGlu
565570575
SerMetLeuAlaTrpIleAspArgGlyIleArgArgGlySerAspGly
580585590
LeuTrpAspProGluLeuTrpGlnLeuGlyAspTrpLeuAspProThr
595600605
AlaProProGluGluProGlyAspAlaArgThrSerGlyThrLeuVal
610615620
AlaAspAlaTyrLeuValHisIleThrSerValMetSerGluIleSer
625630635640
GlnValLeuGlyGlnSerGlnAspAlaAlaArgPheLysThrAspTyr
645650655
AsnArgLeuLysAlaArgPheGlnAlaLysTyrIleThrAlaThrGly
660665670
LeuLeuValGlyAspThrGlnThrAlaLeuSerLeuAlaIleValTyr
675680685
AspLeuHisSerThrProGluAlaAlaGlnAlaAlaAlaSerArgLeu
690695700
ValHisLeuValArgLeuAlaLysPheArgValAlaThrGlyPheAla
705710715720
GlyThrProIleIleThrHisAlaLeuThrLysSerGlyAsnProGln
725730735
IleAlaTyrArgMetLeuLeuGluLysSerArgProSerTrpMetTyr
740745750
ProIleThrMetGlyAlaThrThrMetTrpGluArgTrpAspSerMet
755760765
LeuProAspGlySerIleAsnProGlyGluMetThrSerPheAsnHis
770775780
TyrAlaLeuGlySerIleIleAsnTrpLeuHisSerValValAlaGly
785790795800
ValSerProLeuAlaProGlyTrpLysHisIleGlnValAlaProThr
805810815
ProGlyProThrIleHisSerAlaGluAlaMetTyrAspThrProTyr
820825830
GlyArgLeuGluCysArgTrpSerIleGluThrAspAlaAspArgPhe
835840845
HisMetAspLeuLeuIleProProAsnSerArgAlaArgValIleLeu
850855860
ProThrArgGluLysLeuSerGlnProValGlySerArgGluAspGly
865870875880
GlyPheTrpValGlySerGlyArgHisLysPheSerAlaThrPheGlu
885890895
TrpLysAspTyrSerArgAspTrpProProLysProLeuAsnProIle
900905910
MetArgGluProGluProGluAspIleAla
915920
<210>5
<211>35
<212>DNA
<213>artificial sequence
<400>5
ggaattccatatggccagccaaatcttcattgaaa35
<210>6
<211>34
<212>DNA
<213>artificial sequence
<400>6
cccaagcttggcaatatcctccggttcaggttca34
<210>7
<211>35
<212>DNA
<213>artificial sequence
<400>7
ggaattccatatggccagccaaatcttcattgaaa35
<210>8
<211>34
<212>DNA
<213>artificial sequence
<400>8
cccaagcttggcaatatcctccggttcaggttca34

Claims (6)

1. the method that an enzyme process prepares rare ginsenoside Rh1, it is characterized in that the α-rhamnosidase utilizing the beta-glucosidase deriving from Thermotogapetrophila and aspergillus niger (Aspergillusniger), degraded ginsenoside Re produces Rh1。
2. the method that enzyme process described in claim 1 prepares rare ginsenoside Rh1, it is characterised in that the nucleotide sequence of beta-glucosidase is such as shown in SEQIDNO:1, and aminoacid sequence is such as shown in SEQIDNO:2。
3. the method that enzyme process described in claim 1 prepares rare ginsenoside Rh1, it is characterised in that the nucleotide sequence of α-rhamnosidase is such as shown in SEQIDNO:3, and aminoacid sequence is such as shown in SEQIDNO:4。
4. the method that enzyme process described in claim 1 prepares rare ginsenoside Rh1, it is characterised in that described beta-glucosidase is by recombinant expressed preparation, and step is:
(1) with the Thermotogapetrophila genomic DNA of extraction for template, being classified as forward primer with having the nucleotides sequence shown in SEQIDNO:5 and have the nucleotides sequence shown in SEQIDNO:6 and be classified as downstream primer, pcr amplification obtains the DNA molecular of beta-glucosidase;
(2) DNA molecular of above-mentioned beta-glucosidase and pET-20b are carried out double digestion with NdeI and XhoI respectively, connect and convert the recombiant plasmid obtaining the DNA molecular containing beta-glucosidase;
(3) by recombinant plasmid transformed expressive host E.coliBL21 (DE3) of above-mentioned acquisition, IPTG induces beta-glucosidase expression of enzymes, collects thalline, smudge cells, 80 DEG C of heat treatments 40 minutes, it is thus achieved that the beta-glucosidase of purification。
5. the method that enzyme process described in claim 1 prepares rare ginsenoside Rh1, it is characterised in that described α-rhamnosidase is by recombinant expressed preparation, and step is:
(1) with aspergillus niger (Aspergillusniger) NL-1cDNA of extraction for template, being classified as forward primer with having the nucleotides sequence shown in SEQIDNO:7 and have the nucleotides sequence shown in SEQIDNO:8 and be classified as downstream primer, pcr amplification obtains the DNA molecular of α-rhamnosidase;
(2) DNA molecular of above-mentioned beta-glucosidase and pET-20b are carried out double digestion with NdeI and XhoI respectively, connect and convert the recombiant plasmid obtaining the DNA molecular containing α-rhamnosidase;
(3) by recombinant plasmid transformed expressive host E.coliBL21 (DE3) of above-mentioned acquisition, induce α-rhamnoside expression of enzymes, collect thalline, smudge cells, be centrifuged and obtain α-rhamnosidase。
6. the method that enzyme process prepares rare ginsenoside Rh1 according to claim 1, it is characterised in that degradation condition is:
(1) 1g/L ginsenoside Re, under beta-glucosidase 0.2U, pH5.0,85 DEG C condition, degrade 1h;
(2) above-mentioned reactant liquor being added α-rhamnosidase 6.6U, adjusting pH is under 6.5,35 DEG C of conditions, and degrade 1h, and ginsenoside Re may finally be converted into ginsenoside Rh1, and molar yield is 95%。
CN201610219039.1A 2016-04-08 2016-04-08 Method using enzymatic method to prepare rare ginsenoside Rh1 Pending CN105695552A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610219039.1A CN105695552A (en) 2016-04-08 2016-04-08 Method using enzymatic method to prepare rare ginsenoside Rh1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610219039.1A CN105695552A (en) 2016-04-08 2016-04-08 Method using enzymatic method to prepare rare ginsenoside Rh1

Publications (1)

Publication Number Publication Date
CN105695552A true CN105695552A (en) 2016-06-22

Family

ID=56218565

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610219039.1A Pending CN105695552A (en) 2016-04-08 2016-04-08 Method using enzymatic method to prepare rare ginsenoside Rh1

Country Status (1)

Country Link
CN (1) CN105695552A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106954722A (en) * 2017-05-12 2017-07-18 南京林业大学 A kind of ginkgo tea drink for improving palatability and health-care efficacy and its preparation method and application
CN107641621A (en) * 2017-06-14 2018-01-30 江苏康缘药业股份有限公司 The method that a kind of glucosides enzymatic compositions and enzyme process prepare epimedium aglucone
CN111662831A (en) * 2020-06-12 2020-09-15 浙江工业大学 Aspergillus niger Rha-N1 and application thereof
CN117535372A (en) * 2023-10-23 2024-02-09 镇江市德尔生物制品研究所有限公司 Beta-glucosidase and application thereof in preparation of ginsenoside

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1229086A (en) * 1999-03-17 1999-09-22 金凤燮 Method for preparing rare ginsengoside using enzymatic method to modify ginsenoside glycoside
WO2012070724A1 (en) * 2010-11-24 2012-05-31 한국생명공학연구원 Alpha-n-arabinofuranosidase derived from rhodanobacter ginsenosidimutans and uses thereof
CN104312996A (en) * 2014-09-26 2015-01-28 南京林业大学 Alpha-L-rhamnosidase Rha1 as well as expressed gene and application of alpha-L-rhamnosidase Rha1
CN104328098A (en) * 2014-09-28 2015-02-04 江苏康缘药业股份有限公司 [Beta]-glucosidase, preparation method and application thereof
CN104611313A (en) * 2015-01-19 2015-05-13 南京林业大学 Beta-glucosidase as well as preparation method and application thereof
CN104762281A (en) * 2015-03-09 2015-07-08 南京林业大学 Alpha-L-rhamnosidase and preparing method and applications thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1229086A (en) * 1999-03-17 1999-09-22 金凤燮 Method for preparing rare ginsengoside using enzymatic method to modify ginsenoside glycoside
WO2012070724A1 (en) * 2010-11-24 2012-05-31 한국생명공학연구원 Alpha-n-arabinofuranosidase derived from rhodanobacter ginsenosidimutans and uses thereof
CN104312996A (en) * 2014-09-26 2015-01-28 南京林业大学 Alpha-L-rhamnosidase Rha1 as well as expressed gene and application of alpha-L-rhamnosidase Rha1
CN104328098A (en) * 2014-09-28 2015-02-04 江苏康缘药业股份有限公司 [Beta]-glucosidase, preparation method and application thereof
CN104611313A (en) * 2015-01-19 2015-05-13 南京林业大学 Beta-glucosidase as well as preparation method and application thereof
CN104762281A (en) * 2015-03-09 2015-07-08 南京林业大学 Alpha-L-rhamnosidase and preparing method and applications thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
EUN-AH BAE 等: "Metabolism of Ginsenoside Re by Human Intestinal Microflora and Its Estrogenic Effect", 《BIOL. PHARM. BULL.》 *
HONGSHAN YU 等: "Purification and Characterization of Ginsenoside-a-L-Rhamnosidase", 《CHEM. PHARM. BULL.》 *
张春枝: "人参皂苷糖基水解酶的研究", 《中国博士学位论文全文数据库 工程科技Ⅰ辑》 *
张林河 等: "微生物来源柚苷酶的研究进展及应用", 《化工进展》 *
高娟: "糖苷酶转化人参皂苷的研究", 《中国博士学位论文全文数据库 农业科技辑》 *
龚苏晓: "酶解制备人参皂苷Rg2、Rh1、F1", 《国外医学中医中药分册》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106954722A (en) * 2017-05-12 2017-07-18 南京林业大学 A kind of ginkgo tea drink for improving palatability and health-care efficacy and its preparation method and application
CN106954722B (en) * 2017-05-12 2020-07-31 南京林业大学 Ginkgo tea beverage capable of improving palatability and health care effect and preparation method and application thereof
CN107641621A (en) * 2017-06-14 2018-01-30 江苏康缘药业股份有限公司 The method that a kind of glucosides enzymatic compositions and enzyme process prepare epimedium aglucone
CN111662831A (en) * 2020-06-12 2020-09-15 浙江工业大学 Aspergillus niger Rha-N1 and application thereof
CN117535372A (en) * 2023-10-23 2024-02-09 镇江市德尔生物制品研究所有限公司 Beta-glucosidase and application thereof in preparation of ginsenoside

Similar Documents

Publication Publication Date Title
CN104611313B (en) A kind of β glucuroides and preparation method and application
CN105695552A (en) Method using enzymatic method to prepare rare ginsenoside Rh1
CN106995829A (en) A kind of method that enzymatic conversion method barren wort total chromocor prepares epimedium aglucone
CN104762281B (en) A kind of α rhamnosidases and its preparation method and application
CN104312996B (en) Alpha-L-rhamnosidase Rha1 as well as expressed gene and application of alpha-L-rhamnosidase Rha1
CN107641621A (en) The method that a kind of glucosides enzymatic compositions and enzyme process prepare epimedium aglucone
CN107384896B (en) Enzyme composition for preparing rare ginsenoside and application thereof
CN107828806A (en) A kind of β alpha-glucosidase genes of new resistance to glucose and its application
CN105734092B (en) A kind of method that enzyme process prepares D-Tag
CN104328098A (en) [Beta]-glucosidase, preparation method and application thereof
CN108384769B (en) High-temperature-resistant complex enzyme and application thereof
CN105695553A (en) Method using enzymatic method to prepare rare ginsenoside 20(S)-Rg3
CN117487781A (en) Beta-glucosidase mutant and application thereof in production of rare ginsenoside
CN105385700A (en) Glucosyltransferase gene, preparation method of glucosyltransferase gene, recombinant engineering bacterium and construction method and application of recombinant engineering bacterium
CN111676206A (en) Truncated mutant of alpha-L-rhamnosidase and application thereof
CN114107341A (en) Application of alpha-L-rhamnosidase from fungi in high-efficiency production of icariin
CN106119180A (en) A kind of mycobacteria recombination engineering bacteria and application thereof
Kim et al. Cloning and Expression of $\beta $-Glucuronidase from Lactobacillus brevis in E. coli and Application in Bioconversion of Baicalin and Wogonoside
CN113186210A (en) Atractylodes lancea squalene synthase gene AlSQS1 and coded product and application thereof
CN105112433A (en) Novel coding gene of Type-I pullulanase, and recombinant expression and application thereof
CN104480127A (en) Hyperthermophilic glycosidase mutant and application thereof in preparation of ginsenoside CK
CN104651336B (en) α L arabinofuranosidases and its application in ginsenoside Rd is prepared
CN113373168B (en) Bacterial-derived alpha-L-rhamnosidase gene, gene expression and application thereof
CN101519652A (en) Trehalose synthetase as well as encoding genes and application thereof
CN103146723B (en) Heat-resisting glycosidase gene and soluble expression and application method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160622